Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Stephanie Monaghan O'brien currently holds 5,750 shares of Apellis Pharmaceuticals, Inc. (APLS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephanie Monaghan O'brien has been a net neutral trader of APLS stock. They have purchased $0 and sold $0 worth of shares.
Stephanie Monaghan O'brien's most recent insider trade was on Apr 6, 2026, when they sold 5,750 shares at $0.00 per share.
Stephanie Monaghan O'brien serves as Executive at Apellis Pharmaceuticals, Inc. (APLS). They have executed 5 insider transactions totaling $0 over their tenure at the company.
Stephanie Monaghan O'brien holds the position of Executive at Apellis Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Stephanie Monaghan O'brien has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Stephanie Monaghan O'brien was on Jan 1, 2024, when they purchased $344.1K worth of APLS shares. This transaction involved 5,748 shares at $59.86 per share.
Stephanie Monaghan O'brien currently owns 5,750 shares of Apellis Pharmaceuticals, Inc. (APLS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Stephanie Monaghan O'brien's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Stephanie Monaghan O'brien has 5 Form 4 filings on record as an insider at Apellis Pharmaceuticals, Inc..
Set alerts for Stephanie Monaghan O'brien and 40,000+ other insiders.